Jill Bargonetti

7.0k total citations · 3 hit papers
73 papers, 5.8k citations indexed

About

Jill Bargonetti is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jill Bargonetti has authored 73 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 54 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Jill Bargonetti's work include Cancer-related Molecular Pathways (60 papers), RNA modifications and cancer (19 papers) and DNA Repair Mechanisms (17 papers). Jill Bargonetti is often cited by papers focused on Cancer-related Molecular Pathways (60 papers), RNA modifications and cancer (19 papers) and DNA Repair Mechanisms (17 papers). Jill Bargonetti collaborates with scholars based in United States, Albania and Norway. Jill Bargonetti's co-authors include Carol Prives, Paula N. Friedman, James J. Manfredi, Arnold J. Levine, Carol Prives, Nicoleta C. Arva, Agustin Chicas, George E. Farmer, Hua Zhu and Ron Prywes and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jill Bargonetti

70 papers receiving 5.7k citations

Hit Papers

A Single Nucleotide Polymorphism in the MDM2 Promoter At... 1992 2026 2003 2014 2004 2012 1992 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans
    2004 1.0k citations Gareth L. Bond, Wenwei Hu et al. Cell profile →
  2. Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
    2012 696 citations William A. Freed-Pastor, Hideaki Mizuno et al. Cell profile →
  3. Wild-type p53 activates transcription in vitro
    1992 517 citations Jill Bargonetti, Paula N. Friedman et al. profile →

Peers

Jill Bargonetti
Galina Selivanova Sweden
Peter M. Chumakov Russia
Michael H.G. Kubbutat Germany
Sheau-Yann Shieh Taiwan
Alberto Inga Italy
Andrei L. Gartel United States
James J. Manfredi United States
Kathleen Forrester United States
Raymond E. Meyn United States
Daniel Medina United States
Galina Selivanova Sweden
Jill Bargonetti
Citations per year, relative to Jill Bargonetti Jill Bargonetti (= 1×) peers Galina Selivanova

Countries citing papers authored by Jill Bargonetti

Since Specialization
Citations

This map shows the geographic impact of Jill Bargonetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Bargonetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Bargonetti more than expected).

Fields of papers citing papers by Jill Bargonetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Bargonetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Bargonetti. The network helps show where Jill Bargonetti may publish in the future.

Co-authorship network of co-authors of Jill Bargonetti

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Bargonetti. A scholar is included among the top collaborators of Jill Bargonetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Bargonetti. Jill Bargonetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Juan, Jie Liu, Dandan Xu, et al.. (2025). Lipogenic enzyme FASN promotes mutant p53 accumulation and gain-of-function through palmitoylation. Nature Communications. 16(1). 1762–1762. 3 indexed citations
2.
Ellison, Viola, Alla Polotskaia, Gu Xiao, et al.. (2025). A cancer persistent DNA repair circuit driven by MDM2, MDM4 (MDMX), and mutant p53 for recruitment of MDC1 and 53BP1 on chromatin. Nucleic Acids Research. 53(13).
3.
Wang, Jianming, Xue Yang, Jill Bargonetti, et al.. (2024). p53 suppresses MHC class II presentation by intestinal epithelium to protect against radiation-induced gastrointestinal syndrome. Nature Communications. 15(1). 137–137. 13 indexed citations
4.
Ellison, Viola, Chong Gao, Alexandra Kern, et al.. (2024). Chemokine CXCL12 Activates CXC Receptor 4 Metastasis Signaling Through the Upregulation of a CXCL12/CXCR4/MDMX (MDM4) Axis. Cancers. 16(24). 4194–4194. 1 indexed citations
5.
Ellison, Viola, et al.. (2022). The C-terminus of Gain-of-Function Mutant p53 R273H Is Required for Association with PARP1 and Poly-ADP-Ribose. Molecular Cancer Research. 20(12). 1799–1810. 2 indexed citations
6.
Xiao, Gu, et al.. (2020). Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide. Molecular Pharmaceutics. 18(1). 338–346. 3 indexed citations
7.
Xiao, Gu, et al.. (2020). <p>MDM2-C Functions as an E3 Ubiquitin Ligase</p>. Cancer Management and Research. Volume 12. 7715–7724. 9 indexed citations
8.
Xiao, Gu, Viola Ellison, Alla Polotskaia, et al.. (2019). Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer. Cancer Research. 80(3). 394–405. 47 indexed citations
9.
Loo, Lenora W. M., et al.. (2018). MDM2, MDM2-C, and mutant p53 expression influence breast cancer survival in a multiethnic population. Breast Cancer Research and Treatment. 174(1). 257–269. 10 indexed citations
10.
Shtraizent, Nataly, et al.. (2014). Impedimetric Detection of Mutant p53 Biomarker-Driven Metastatic Breast Cancers under Hyposmotic Pressure. PLoS ONE. 9(6). e99351–e99351. 7 indexed citations
11.
Freed-Pastor, William A., Hideaki Mizuno, Xi Zhao, et al.. (2012). Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway. Cell. 148(1-2). 244–258. 696 indexed citations breakdown →
12.
Rodriguez, Olga, Vamsi Krishna Kolukula, Eveline E. Vietsch, et al.. (2012). Dietary downregulation of mutant p53 levels via glucose restriction. Cell Cycle. 11(23). 4436–4446. 96 indexed citations
13.
Bond, Gareth L., Wenwei Hu, Elisabeth E. Bond, et al.. (2004). A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans. Cell. 119(5). 591–602. 1026 indexed citations breakdown →
14.
Abbas, Tarek, David White, Hui Li, et al.. (2004). Inhibition of Human p53 Basal Transcription by Down-regulation of Protein Kinase Cδ. Journal of Biological Chemistry. 279(11). 9970–9977. 55 indexed citations
15.
Bargonetti, Jill, et al.. (2003). In Vivo Footprinting and DNA Affinity Chromatography for Analysis of p53 DNA Binding Ability. Humana Press eBooks. 234. 151–170. 2 indexed citations
16.
Bargonetti, Jill & James J. Manfredi. (2002). Multiple roles of the tumor suppressor p53. Current Opinion in Oncology. 14(1). 86–91. 299 indexed citations
17.
Chicas, Agustin, Patricia E. Molina, & Jill Bargonetti. (2000). Mutant p53 Forms a Complex with Sp1 on HIV-LTR DNA. Biochemical and Biophysical Research Communications. 279(2). 383–390. 56 indexed citations
18.
Boydston‐White, Susie, et al.. (1999). Infrared spectroscopy of human tissue. V. Infrared spectroscopic studies of myeloid leukemia (ML-1) cells at different phases of the cell cycle. Biospectroscopy. 5(4). 219–227. 141 indexed citations
19.
Prives, Carol, et al.. (1991). Functional Consequences of the Interactions of the p53 Tumor Suppressor Protein and SV40 Large Tumor Antigen. Cold Spring Harbor Symposia on Quantitative Biology. 56(0). 227–235. 10 indexed citations
20.
Bargonetti, Jill, Paula N. Friedman, Scott E. Kern, Bert Vogelstein, & Carol Prives. (1991). Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell. 65(6). 1083–1091. 327 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Galina Selivanova Breakdown of academic impact, for papers by Peter M. Chumakov Breakdown of academic impact, for papers by Michael H.G. Kubbutat Breakdown of academic impact, for papers by Sheau-Yann Shieh Breakdown of academic impact, for papers by Alberto Inga Breakdown of academic impact, for papers by Andrei L. Gartel Breakdown of academic impact, for papers by James J. Manfredi Breakdown of academic impact, for papers by Kathleen Forrester Breakdown of academic impact, for papers by Raymond E. Meyn Breakdown of academic impact, for papers by Daniel Medina
Rankless by CCL
2026